Oberon Investments Group PLC
19 August 2026
The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
19 August 2026
Oberon Investments Group plc
("Oberon", the "Company", or the "Group")
£1.4 million Fundraise at Current Offer Price
Strong support from existing and new investors
Oberon Investments Group plc (AQSE: OBE), the integrated investment management, financial planning, asset management and corporate advisory group, is pleased to announce that it has raised approximately £1.4 million before expenses through the issue of approximately 68,761,899 new ordinary shares of 0.5 pence each in the Company (the "Fundraising Shares") at a price of 2.1 pence per share (the "Issue Price") (the "Fundraise").
The Issue Price was equal to the Company's current offer price at the time the Fundraise was agreed.
The Fundraise received strong support from existing and new investors, together with significant participation from staff and directors of the Group. £400,000 of the Fundraise was subscribed by existing VCT and institutional investors and approximately £300,000 of the total amount raised has been subscribed by Oberon staff and directors. The Board believes this demonstrates a strong level of internal confidence in the Group's strategy and prospects.
As part of the Fundraise, Jonathan Eddis, the Company's recently appointed Non-Executive Director, and Michael Cuthbert, Chairman of the Company, have each subscribed for 476,190 Ordinary Shares at the Issue Price.
Following admission of the Fundraising Shares ("Admission"), Jonathan Eddis will hold 476,190 Ordinary Shares, representing approximately 0.05% of the enlarged issued share capital. Michael Cuthbert will hold 1,481,735 Ordinary Shares, representing approximately 0.17% of the enlarged issued share capital.
The proceeds will further strengthen the Group's financial position and provide additional working capital as Oberon continues to execute its growth strategy.
Related Party Transaction
The participation of Jonathan Eddis and Michael Cuthbert in the fundraise constitutes a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Rules by virtue of their positions as directors of the Company.
The Directors independent of the transaction, having exercised reasonable care, skill and diligence, consider that the terms of the subscriptions by Jonathan Eddis and Michael Cuthbert are fair and reasonable insofar as the shareholders of the Company are concerned.
Admission and Total Voting Rights
Application will be made for the 68,761,899 Fundraising Shares, which, when issued, will be credited as fully paid and will rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on the AQSE Growth Market.
It is expected that Admission will become effective and dealings in the Fundraising Shares will commence on or around 8:00 a.m. on 21 August 2026.
Following Admission, the Company's issued ordinary share capital will comprise 868,710,940 Ordinary Shares, each carrying one voting right. The Company does not hold any Ordinary Shares in treasury. Accordingly, the total number of voting rights in the Company will be 868,710,940. This figure may be used by shareholders as the denominator for calculations by which they determine whether they are required to notify their interest in, or a change to their interest in, the Company under the applicable disclosure requirements.
Simon McGivern, Chief Executive Officer of Oberon Investments Group, commented:
"We are delighted with the strong support shown for this fundraise from both existing and new investors. Raising £1.4 million at the current offer price provides further backing for the Group as we continue to grow the business and focus on converting that growth into sustainable profitability.
It is particularly encouraging that approximately £300,000 has been invested by our own staff and directors. We have always believed strongly in alignment between the people building Oberon and our shareholders, and this represents a meaningful vote of confidence from within the business.
I am also delighted that both our Chairman, Mike Cuthbert, and our newly appointed Non-Executive Director, Jonathan Eddis, have invested personally in the fundraise.
We enter the new financial year with a stronger business, an increasingly recurring revenue base and continued support from both our people and our shareholders."
For further information please contact:
Oberon Investments Group plc https://oberoninvestments.com
Simon McGivern / Marcia Manarin
via Strand Hanson
Strand Hanson Limited
(AQSE Corporate Adviser to the Company)
+44 (0)20 7409 3494
Ritchie Balmer / James Spinney / Imogen Ellis
Oberon Capital
(Broker to the Company)
+44 (0)20 3179 5300
Mike Seabrook / Nick Lovering
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Jonathan Eddis
1. Details of the person discharging managerial responsibilities / person closely associated
Name: Jonathan Eddis
2. Reason for the notification
Position/status: Non-Executive Director
Initial notification / Amendment: Initial notification
3. Details of the issuer
Name: Oberon Investments Group plc
LEI: 21380024SB7KJSJ69U67
4. Details of the transaction
Description of financial instrument: Ordinary shares of 0.5p each
ISIN: GB00BDZRYX75
Nature of transaction: Subscription for new Ordinary Shares pursuant to the Fundraise
Price: 2.1 pence per share
Volume: 476,190 Ordinary Shares
Aggregate consideration: £9,999.99
Date of transaction: 19 August 2026
Place of transaction: Aquis Stock Exchange
Michael Cuthbert
1. Details of the person discharging managerial responsibilities / person closely associated
Name: Michael Cuthbert
2. Reason for the notification
Position/status: Chairman
Initial notification / Amendment: Initial notification
3. Details of the issuer
Name: Oberon Investments Group plc
LEI: 21380024SB7KJSJ69U67
4. Details of the transaction
Description of financial instrument: Ordinary shares of 0.5p each
ISIN: GB00BDZRYX75
Nature of transaction: Subscription for new Ordinary Shares pursuant to the Fundraise
Price: 2.1 pence per share
Volume: 476,190 Ordinary Shares
Aggregate consideration: £9,999.99
Date of transaction: 19 August 2026
Place of transaction: Aquis Stock Exchange
OBR00503
Important Notices
Oberon Investments Limited (trading as Oberon Capital) is authorised and regulated by the Financial Conduct Authority (the "FCA") in the United Kingdom and is acting exclusively for the Company and no one else in connection with the Fundraising and will not regard anyone (including any subscribers) (whether or not a recipient of this Announcement) as a client, and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Fundraising or any other matters referred to in this Announcement.
Neither this Announcement, nor any copy of it, nor the information contained in it, is for publication, release, transmission, distribution or forwarding, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which publication, release or distribution would be unlawful (or to any persons in any of those jurisdictions). This Announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for shares in the capital of the Company in the United States, Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction (or to any persons in any of those jurisdictions). This Announcement has not been approved by the London Stock Exchange. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.
The Fundraising Shares have not been, and will not be, registered under the US Securities Act or with any securities regulatory authority or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, pledged, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States.
No public offering of securities is being made in the United States. The Fundraising Shares have not been approved, disapproved or recommended by the U.S. Securities and Exchange Commission, any state securities commission in the United States or any other U.S. regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Fundraising Shares. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United States, Australia, Canada, Japan or the Republic of South Africa or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, Japan or the Republic of South Africa. No public offering of the Fundraising Shares is being made in the United States, United Kingdom or elsewhere. All offers of the Fundraising Shares will be made pursuant to an exemption from the requirement to produce a prospectus under the EU Prospectus Regulation or the UK Prospectus Regulation.
This Announcement is not being distributed by, nor has it been approved for the purposes of section 21 of FSMA by, a person authorised under FSMA. This Announcement is being distributed and communicated to persons in the United Kingdom only in circumstances in which section 21(1) of FSMA does not apply.
The distribution of this Announcement, the Fundraising and/or the offering of the Fundraising Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company or its affiliates that would permit an offering of the Fundraising Shares or possession or distribution of this Announcement or any other offering or publicity material relating to the Fundraising Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company to inform themselves about, and to observe, such restrictions.
This Announcement may contain and the Company may make verbal statements containing "forward-looking statements" with respect to certain of the Company's plans and its current goals and expectations relating to its future financial condition, performance, strategic initiatives, objectives and results. Forward-looking statements sometimes use words such as "aim", "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "seek", "may", "could", "outlook" or other words of similar meaning. By their nature, all forward-looking statements involve risk and uncertainty because they relate to future events and circumstances which are beyond the control of the Company. As a result, the actual future financial condition, performance and results of the Company may differ materially from the plans, goals and expectations set forth in any forward-looking statements. Any forward looking statements made in this Announcement by or on behalf of the Company speak only as of the date they are made. These forward-looking statements reflect the Company's judgment at the date of this Announcement and are not intended to give any assurance as to future results and the Company cautions that its actual results of operations and financial condition, and the development of the industry in which it operates, may differ materially from those made in or suggested by the forward-looking statements contained in this Announcement and/or information incorporated by reference into this Announcement. The information contained in this Announcement is subject to change without notice and except as required by applicable law or regulation, the Company expressly disclaims any obligation or undertaking to publish any updates, supplements or revisions to any forward-looking statements contained in this Announcement to reflect any changes in the Company's expectations with regard thereto or any changes in events, conditions or circumstances on which any such statements are based, except where required to do so under applicable law.
No statement in this Announcement is intended to be a profit forecast or estimate, and no statement in this Announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.
Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this Announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.